These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30193189)

  • 1. Brain neurokinin-1 receptor availability in never-medicated patients with major depression - A pilot study.
    Nyman M; Eskola O; Kajander J; Jokinen R; Penttinen J; Karjalainen T; Nummenmaa L; Hirvonen J; Burns D; Hargreaves R; Solin O; Hietala J
    J Affect Disord; 2019 Jan; 242():188-194. PubMed ID: 30193189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender and age affect NK1 receptors in the human brain - a positron emission tomography study with [18F]SPA-RQ.
    Nyman MJ; Eskola O; Kajander J; Vahlberg T; Sanabria S; Burns D; Hargreaves R; Solin O; Hietala J
    Int J Neuropsychopharmacol; 2007 Apr; 10(2):219-29. PubMed ID: 16573846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential.
    Herpfer I; Lieb K
    CNS Drugs; 2005; 19(4):275-93. PubMed ID: 15813642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies.
    Ratti E; Bettica P; Alexander R; Archer G; Carpenter D; Evoniuk G; Gomeni R; Lawson E; Lopez M; Millns H; Rabiner EA; Trist D; Trower M; Zamuner S; Krishnan R; Fava M
    J Psychopharmacol; 2013 May; 27(5):424-34. PubMed ID: 23539641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the phenotype of NK1R-/- mice with pharmacological blockade of the substance P (NK1 ) receptor in assays for antidepressant and anxiolytic drugs.
    Rupniak NM; Carlson EJ; Webb JK; Harrison T; Porsolt RD; Roux S; de Felipe C; Hunt SP; Oates B; Wheeldon A
    Behav Pharmacol; 2001 Nov; 12(6-7):497-508. PubMed ID: 11742144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striatal dopamine D2/3 receptor-mediated neurotransmission in major depression: Implications for anhedonia, anxiety and treatment response.
    Peciña M; Sikora M; Avery ET; Heffernan J; Peciña S; Mickey BJ; Zubieta JK
    Eur Neuropsychopharmacol; 2017 Oct; 27(10):977-986. PubMed ID: 28870407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of efficacy of the substance p (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder.
    Keller M; Montgomery S; Ball W; Morrison M; Snavely D; Liu G; Hargreaves R; Hietala J; Lines C; Beebe K; Reines S
    Biol Psychiatry; 2006 Feb; 59(3):216-23. PubMed ID: 16248986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance P and the Neurokinin-1 Receptor: The New CRF.
    Schank JR; Heilig M
    Int Rev Neurobiol; 2017; 136():151-175. PubMed ID: 29056150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging substance P receptors (NK1) in the living human brain using positron emission tomography.
    Hargreaves R
    J Clin Psychiatry; 2002; 63 Suppl 11():18-24. PubMed ID: 12562139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcohol-induced conditioned place preference negatively correlates with anxiety-like behavior in adolescent mice: inhibition by a neurokinin-1 receptor antagonist.
    Huang H; Zhang X; Fu X; Zhang X; Lang B; Xiang X; Hao W
    Psychopharmacology (Berl); 2018 Oct; 235(10):2847-2857. PubMed ID: 30054674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.
    Ninan PT; Shelton RC; Bao W; Guico-Pabia CJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():86-91. PubMed ID: 24096053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disproportionate Reduction of Serotonin Transporter May Predict the Response and Adherence to Antidepressants in Patients with Major Depressive Disorder: A Positron Emission Tomography Study with 4-[18F]-ADAM.
    Yeh YW; Ho PS; Kuo SC; Chen CY; Liang CS; Yen CH; Huang CC; Ma KH; Shiue CY; Huang WS; Shyu JF; Wan FJ; Lu RB; Huang SY
    Int J Neuropsychopharmacol; 2015 Jan; 18(7):pyu120. PubMed ID: 25568284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased neurokinin-1 receptor availability in temporal lobe epilepsy: a positron emission tomography study using [(11)C]GR205171.
    Danfors T; Åhs F; Appel L; Linnman C; Fredrikson M; Furmark T; Kumlien E
    Epilepsy Res; 2011 Nov; 97(1-2):183-9. PubMed ID: 21925840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tachykinin NK1 receptor antagonist L-733,060 and substance P deletion exert neuroprotection through inhibiting oxidative stress and cell death after traumatic brain injury in mice.
    Li Q; Wu X; Yang Y; Zhang Y; He F; Xu X; Zhang Z; Tao L; Luo C
    Int J Biochem Cell Biol; 2019 Feb; 107():154-165. PubMed ID: 30593954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptom provocation in specific phobia affects the substance P neurokinin-1 receptor system.
    Michelgård A; Appel L; Pissiota A; Frans O; Långström B; Bergström M; Fredrikson M
    Biol Psychiatry; 2007 Apr; 61(8):1002-6. PubMed ID: 16950220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased neurokinin-1 receptor availability in the amygdala in social anxiety disorder: a positron emission tomography study with [11C]GR205171.
    Frick A; Ahs F; Linnman C; Jonasson M; Appel L; Lubberink M; Långström B; Fredrikson M; Furmark T
    Transl Psychiatry; 2015 Jul; 5(7):e597. PubMed ID: 26151925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overlapping expression of serotonin transporters and neurokinin-1 receptors in posttraumatic stress disorder: a multi-tracer PET study.
    Frick A; Åhs F; Palmquist ÅM; Pissiota A; Wallenquist U; Fernandez M; Jonasson M; Appel L; Frans Ö; Lubberink M; Furmark T; von Knorring L; Fredrikson M
    Mol Psychiatry; 2016 Oct; 21(10):1400-7. PubMed ID: 26619809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between amygdala neurokinin-1 receptor availability and anxiety-related personality traits.
    Hoppe JM; Frick A; Åhs F; Linnman C; Appel L; Jonasson M; Lubberink M; Långström B; Frans Ö; von Knorring L; Fredrikson M; Furmark T
    Transl Psychiatry; 2018 Aug; 8(1):168. PubMed ID: 30154470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis of the efficacy of venlafaxine extended release 75-225 mg/day for the treatment of major depressive disorder.
    Thase M; Asami Y; Wajsbrot D; Dorries K; Boucher M; Pappadopulos E
    Curr Med Res Opin; 2017 Feb; 33(2):317-326. PubMed ID: 27794623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.